Sponsor Dossier
Theramex
Sponsor Dossier for Theramex. ARTG portfolio, PBS-listed brands, PBAC activity, AusPAR record — compiled by arcimedes.
- Brand: ACTONEL
- Brand: BIJUVA
- Brand: ELADYNOS
- Brand: GANIRELIX
- Brand: INTRAROSA
- Brand: OVALEAP
- Brand: OXYTROL
- Brand: SEASONIQUE
- Device (sponsor): Cartridge-accepting autoinjector, mechanical
- Device (sponsor): Needle, injector, medication/vaccine
- Device (sponsor): Cartridge-accepting autoinjector, mechanical
- Device (sponsor): Needle, injector, medication/vaccine
About
Theramex is an Australian Private Company with ABN 37 623 186 845, registered in NSW. The company is currently active.
Portfolio
Theramex has 10 brands on the ARTG, of which 9 are indexable. Eight brands have Product Information on file. Two brands are PBS-listed, five have PBAC outcomes on record, and five have AusPARs on record. Notable brands include ACTONEL, BIJUVA, ELADYNOS, GANIRELIX, INTRAROSA, OVALEAP, OXYTROL, SEASONIQUE, YSELTY, and ZOELY.
Therapeutic focus
— Women's Health: 4 brands — Reproductive Health: 3 brands — Endocrinology: 1 brand — Urology: 1 brand — Musculoskeletal: 1 brand
PBS footprint
Two brands in the Theramex portfolio are PBS-listed, with the latest schedule date being 1 May 2026.
Regulatory activity
The most recent PBAC outcome for Theramex was dated 1 July 2025, with 5 brands on record having PBAC outcomes. The most recent AusPAR was dated 6 November 2024, with 5 brands on record having AusPARs.